1. Home
  2. Press release
Nov 06, 2020 16:00 JST

Source: Showa Denko K.K.

Showa Denko Establishes Joint Corporation in Sichuan, China to Manufacture High-purity Gas for Electronics
Aiming to Cope with the Increase of Demand in China

TOKYO, Nov 06, 2020 - (ACN Newswire) - Showa Denko K.K. (SDK; TSE:4004) has established Chengdu Kemeite Showa Electronic Materials Co., Ltd. in Chengdu, China, jointly with Chengdu Kemeite Special Gas Co., Ltd. of China, aiming to strengthen SDK's business to produce and sell high-purity gases for electronics. The new company will start its operation in January 2021, and it will mainly be in charge of the implementation of final process in the manufacturing process of high-purity FC-14 gas (tetrafluoromethane: CF4) which is used in the process to manufacture semiconductors.

Exterior view of the building of Chengdu Kemeite Special Gas Co., Ltd. where the new company will move in
 


CF4 is one of major products of SDK's electronic gas business. CF4 is the primary and basic etching gas among high-purity gases for electronics, and has been mass-produced and used for more than 40 years. The demand for CF4 is expected to increase steadily because it is not only easy to handle but also suitable for micromachining of semiconductor chips which is improving further, and the amount of CF4 used in the process to produce leading-edge electronic devices including organic electroluminescent displays has been increasing.

Through execution of this buildup policy, SDK's CF4 business will have a system to produce CF4 with two production bases, namely, production facilities in SDK's Kawasaki Plant which is in operation and those in the new company. The Showa Denko Group will really strengthen stability of its system to supply CF4 for East Asian market, and expand its strategic business to provide materials for production process of semiconductors further.

[Outline of the new joint corporation]

Firm name: Chengdu Kemeite Showa Electronic Materials Co., Ltd.
Head office: Pengzhou, Chengdu, Sichuan Province, the People's Republic of China
Establishment: October 30, 2020
Capital: 4 million yuan
Shareholders: Showa Denko K.K. (40%); Chengdu Kemeite Special Gas Co., Ltd. (60%)
Scope of business: Production and sale of high-purity CF4

[Outline of Chengdu Kemeite Special Gas Co., Ltd.]

Firm name: Chengdu Kemeite Special Gas Co., Ltd.
Head office: Pengzhou, Chengdu, Sichuan Province, the People's Republic of China
Scope of business: Production and sale of sulfur hexafluoride (SF6) for industrial use, high-purity CF4, etc.
Number of employees: about 200

Contact:
Showa Denko K.K., CSR & Corporate Communication Office, Tel: 81-3-5470-3235
Source: Showa Denko K.K.
Sectors: Chemicals, Spec.Chem

Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Related Press Release

Showa Denko Announces 2022 2Q Consolidated Financial Results
August 04 2022 14:00 JST
 
Showa Denko Revises Forecast of Consolidated Performance
August 03 2022 14:00 JST
 
Showa Denko Concludes MOU with SK Inc. to Give Consideration to a Plan to Cooperatively Produce High-Purity Gases for Semiconductors in North America
June 29 2022 12:00 JST
 
SDK and Microwave Chemical Start Joint Development of New Microwave-based Chemical Recycling Technology to Directly Transform Used Plastic into Basic Chemical Feedstock
June 28 2022 10:30 JST
 
Showa Denko Announces Record Date for Extraordinary Shareholders' Meeting
May 26 2022 14:00 JST
 
Showa Denko to Consider Simplified Absorption-type Company Split
May 26 2022 14:00 JST
 
Showa Denko Starts Shipment of Newly Developed HD Media for Record-breaking 26TB Near-line HDD
May 26 2022 11:00 JST
 
Showa Denko's Program for 8-inch SiC Wafers for the Next-generation Green Power Semiconductor selected for NEDO's Green Innovation Fund Projects
May 24 2022 17:00 JST
 
Showa Denko Announces 2022 First Quarter Financial Results
May 11 2022 14:00 JST
 
Showa Denko Decides to Raise Chloroprene Rubber Price
April 27 2022 10:30 JST
 
More Press release >>

Latest Press Release


TOPVISION Launches Prospectus for Listing Transfer from LEAP to the ACE Market
Nov 27, 2024 05:53 JST

TOYOTA GAZOO Racing FULLY PREPARED FOR DAKAR 2025
Nov 26, 2024 17:55 JST

Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan
Nov 26, 2024 15:50 JST

Fujitsu develops Policy Twin, a new digital twin technology to maximize effectiveness of local government policies for solving societal issues
Nov 26, 2024 10:51 JST

TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025
Nov 25, 2024 17:10 JST

Toyota Submits Progress Report on Recurrence Prevention Measures
Nov 25, 2024 15:43 JST

TOPVISION Launches Prospectus for Transfer Listing from LEAP to the ACE Market
Nov 25, 2024 15:00 JST

MHI Thermal Systems Receives Order from Aisan Industry for Aquifer Thermal Energy Storage System for Its New Anjo Plant
Nov 25, 2024 14:18 JST

Oracle Red Bull Racing Driver Max Verstappen Wins Fourth Consecutive F1 Drivers' World Championship
Nov 25, 2024 11:55 JST

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST
 More Latest Release >>